Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: Identification of four variants among wild-type EBV isolates

Blood

Volumn 90, Issue 1, 1997, Pages 323-330

  Sandvej, Kristian ^a   Gratama, Jan W ^b   Munch, Mette ^b   Zhou, Xiao Ge ^b   Bolhuis, Reinder L H ^b   Andresen, Brage Storstein ^b   Gregersen, Niels ^b   Hamilton Dutoit, Stephen ^b  

^a University Institute of Pathology Arhus   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MUTATION; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE; VIRUS ISOLATION;

EID: 0030997666     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.323     Document Type: Article

References (37)

1. Rowe M, Pilon MP, Huen DS, Hardy R, Croom-Carter D, Lundgren E, Rickinson A: Upregulation of BCL-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-kB activation and to induction of cell surface markers. J Virol 68:5602, 1994
2. Peng M, Lundgren E: Transient expression of the Epstein-Barr virus LMP-1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 7:1775, 1992
3. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson AB, Larson R, Springer T, Kieff E: Epstein-Barr latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J Virol 62:4173, 1988
4. Kaye KM, Izumi KM, Kieff E: Epstein-Barr virus latent membrane protein-1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150, 1993
5. Wang D, Liebowits D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1985
6. Dawson CW, Rickinson AB, Young LS: Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777, 1990
7. Fåhraeus R, Rymo L, Rhim JL, Klein G: Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447, 1990
8. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ: Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315, 1990
9. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young L: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet ii:320, 1991
10. Young L, Dawson C, Clark D, Rupani H, Busson P, Turz T, Johnsson A, Rickinson A: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051, 1988
11. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399, 1991
12. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575, 1993
13. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131, 1992
14. Jeng KCG, Hsu C-Y, Liu M-T, Chung T-T, Liu S-T: Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumours in Taiwan. J Clin Microbiol 32:28, 1994
15. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt B, Delsol G, Pallesen G: Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal cardnoma. Blood 82:2937, 1993
16. Miller WE, Edwards RH, Walling DM, Raab-Traub N: Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75:2729, 1994
17. Sandvej K, Peh SC, Andresen B, Pallesen G: Identification of potential hot-spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV associated diseases: High frequency of a 30 bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053, 1994
18. Knecht H, Raphael M, McQuain C, Rothenberger S, Pihan G, Camilleri-Broët S, Bachmann E, Kershaw GR, Ryan S, Kittler ELW, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P: Deletion variants within the NF-kB activation domain of the LMP-1 oncogene prevail in acquired immunodeficiency syndrome-related large-cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 87:876, 1996
19. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlation with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242, 1996
20. Santon A, Manzanal AI, Campo E, Bellas C: Deletion in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol: Mol Pathol 48:M184, 1995
21. Gratama JW, Oosterveer MAP, Weimar W, Sintnicolaas K, Sizoo W, Bolhuis RLH, Ernberg I: Detection of multiple "EBNO-types" in individual Epstein-Barr virus (EBV) carriers following lymphocyte transformation by EBV derived from peripheral blood and oropharynx. J Gen Virol 75:85, 1994
22. Kunimoto M, Tamura S, Tabata T, Yoshie O: One step typing of Epstein-Barr virus by polymerase chain reaction: Predominance of type 1 virus in Japan. J Gen Virol 73:455, 1992
23. Knecht H, Bachmann E, Joske DJL, Sahli R, Emery-Goodman A, Casanova JL, Zilic M, Bachmann F, Odermatt BF: Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 7:580, 1993
24. Trividi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G: Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma in non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 30A:84, 1994
25. Li SN, Chang YS, Liu ST: Effect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129, 1996
26. Boyle MJ, Sewell WA, Scully TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA: Subtype of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 78:3004, 1991
27. Huen DS, Henderson SA, Croom-Carter D, Rowe M: The Epstein-Barr virus latent membrane protein-1 (LMP-1) mediates activation of NF-kB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmatic domain. Oncogene 10:549, 1995
28. Moorthy RK, Thorley-Lawson DA: Biochemical, genetic and functional analysis of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J Virol 67:2637, 1993
29. Minarovits J, Hu LF, Minarovits-Kormuta S, Klein G, Ernberg I: Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP-1 and BCR2 enhancer-promoter region. Virology 200:661, 1994
30. Chen ML, Wu RC, Liu ST, Chang YS: Characterization of 5′-upstream sequence of the latent membrane protein 1 (LMP-1) gene of an Epstein-Barr virus identified in nasopharyngeal carcinoma tissues. Virus Res 37:75, 1995
31. Hudson G, Farrell PJ, Barrell BG: Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of the Epstein-Barr virus B95.8. J Virol 53:528, 1985
32. Rowe M, Evans HS, Young L, Hennessy K, Kieff E, Rickinson A: Mononuclear antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus transformed cells. J Gen Virol 68:1575, 1987
33. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523, 1995
34. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG: DNA sequence and expression of the B95.8 Epstein-Barr virus genome. Nature 310:207, 1984
35. Johannesen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman S: Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by Jk and PU.1. J Virol 69:253, 1995
36. Laux G, Adam B, Strobl L, Moreau-Gachelin F: The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-Jk interacts with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J 13:5624, 1994
37. Ghosh D, Kieff E: Cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcription site. J Virol 64:1855, 1990